We present a genome-wide association study of ileal Crohn disease and two independent replication studies that identify several new regions of association to Crohn disease. Specifically, in addition to the previously established CARD15 and IL23R associations, we identified strong and significantly replicated associations (combined P o 10 À10 ) with an intergenic region on 10q21.1 and a coding variant in ATG16L1, the latter of which was also recently reported by another group. We also report strong associations with independent replication to variation in the genomic regions encoding PHOX2B, NCF4 and a predicted gene on 16q24. 1 (FAM92B) . Finally, we demonstrate that ATG16L1 is expressed in intestinal epithelial cell lines and that functional knockdown of this gene abrogates autophagy of Salmonella typhimurium. Together, these findings suggest that autophagy and host cell responses to intracellular microbes are involved in the pathogenesis of Crohn disease.
Crohn disease and ulcerative colitis represent the two common forms of idiopathic inflammatory bowel disease (IBD), each with a prevalence of roughly 100-150 per 100,000 individuals of European ancestry 1 . Crohn disease most commonly involves the ileum and colon but can affect any region of the gut. Ulcerative colitis often involves the rectum, and inflammation may extend as far as the cecum in a contiguous pattern 2 . Strong familial aggregation, twin studies and established genetic associations attest to the important role of genetics in IBD pathogenesis [3] [4] [5] . There is also very strong evidence that the enteric microflora have a central role in the initiation and maintenance of disease. Therefore, like most complex trait diseases, IBD results from a combination of genetic and nongenetic risk factors; each individual factor may be expected to have a relatively modest effect on disease risk.
Although a combination of genome-wide linkage, candidate gene and targeted association mapping studies have been successful in the identification of Crohn disease-associated genetic variants in CARD15 and the IBD5 haplotype, these explain only a small fraction of the heritability of Crohn disease [6] [7] [8] . Therefore, we performed a genomewide association (GWA) study of Crohn disease to find additional genetic risk factors. Phenotypes for Crohn disease and ulcerative colitis vary considerably among individuals, primarily with regard to sites of inflammation, disease behavior, severity and extraintestinal manifestations. Furthermore, Crohn disease site and behavior are probably under genetic control, based on clustering within affected sibling pairs 9 and on specific observations that CARD15 mutations are a greater risk factor for ileal Crohn disease and stricturing behavior 10 .
Therefore, we focused exclusively on individuals with Crohn disease involving the ileal region of the small intestine (with or without other sites of involvement) in an attempt to minimize clinical and genetic heterogeneity. Based on an interim analysis approximately halfway through this study, we identified, confirmed and published several genetic variants in IL23R that significantly influence risk of developing Crohn disease and ulcerative colitis 11 . Specifically, at that point, we had scanned and analyzed 567 non-Jewish individuals with ileal Crohn disease. Here we report the results of the completed scan, in which we genotyped 988 individuals with ileal Crohn disease and 1,007 controls using the Illumina HumanHap300 Genotyping BeadChip and replicated the significantly associated SNPs in independent family-based and case-control studies. We report preliminary functional data that begin to place these newly discovered risk loci into biological context and suggest potential pathogenic mechanisms.
RESULTS

Genome-wide association analysis
In order to identify genetic factors influencing the risk of Crohn disease, we typed 317,503 SNPs using DNA samples from 988 individuals with ileal Crohn disease and 1,007 controls collected by the members of the North American National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC). Overall, 98.6% of genotypes were called in this experiment, but before analysis, we performed quality filtering of both samples and SNPs to ensure robust association tests (see Methods). After performing these data-filtering measures, we had a final data set of genotypes consisting of 304,413 SNPs in 946 affected individuals and 977 controls, with an average call rate of 99.35%. Our baseline analysis was a CochranMantel-Haenszel (CMH) test using two groups (Jewish and nonJewish) to accommodate potential subtle differences in the genetic background of the two groups. The median w 2 was slightly inflated, so we corrected all statistics using a genomic control factor of 1.056.
This genomic control-corrected CMH analysis produced a significant excess of positive associations: for example, 27 SNPs in nine distinct genomic regions were associated with P o 10 À5 , a level that we would informally expect to observe by chance roughly three times in this scan given the number of tests performed ( Fig. 1 and Table 1 ). The two most significant loci, with multiple SNPs significantly associated, corresponded to CARD15 and IL23R, which have been Figure 1 Genome-wide association results for 946 ileal Crohn disease cases and 977 control samples. Single-marker association results for the combined non-Jewish and Jewish samples using the Cochran-Mantel-Haenszel (CMH) test. Each chromosome is depicted as a different color. The red line indicates the threshold (P o 5 Â 10 À5 ) selected to define regions for evaluation in the replication studies. The P value thresholds for suggestive and significant associations are 3.28 Â 10 À6 and 1.64 Â 10 À7 , respectively, based on a Bonferroni correction for multiple testing. A modest correction factor (l ¼ 1.056) is necessary to correct for stratification between cases and controls, but it does not modify the current results.
confirmed previously as IBD genes. The remaining regions identified with extreme P values showed no unusual pattern of missing data or departure from Hardy-Weinberg equilibrium (HWE) in controls (of the best SNPs in the top 23 regions examined further (below), all had HWE P 4 0.01 in controls, and 18 were missing fewer than 1% of genotypes), and many were supported by nearby correlated SNPs also showing association. Notably, the confirmed IBD5 Crohn disease risk haplotype was not among the top loci in this study of ileal Crohn disease, as it had only modest evidence of association (P o 0.01).
Two independent replication studies confirm new IBD risk loci Although encouraging, even a high-quality data set and robust analyses cannot be assumed to filter out all artifactual sources of false positives. Therefore, we tested the most significantly associated SNP in each of the 23 independently associated regions with P o 5 Â 10 À5 in an independent set of 650 individuals with ileal Crohn disease and their parents ('replication cohort 1') to attempt replication of these findings in a robust family-based setting and with an alternative genotyping technology (iPlex; Sequenom). Although we did not succeed in typing three of these SNPs (and the replication of CARD15 and IL23R had already been established and is not considered here), the remaining 18 SNPs had high-quality genotype data that passed our quality thresholds. After removing DNA with low genotype call rates and families with an excess of Mendel errors, the final analyses included 530 trios. Association testing of this final data set from replication cohort 1 identified 6 out of 18 SNPs that had significant evidence of replication ( Table 1 and Supplementary  Table 1 online): rs2241880 (P ¼ 0.00089), rs16853571 (P ¼ 0.00037), rs224136 (P ¼ 0.00021), rs4821544 (P ¼ 0.019), rs8050910 (P ¼ 0.024) and rs11617463 (P ¼ 0.037). To provide further evidence for association of these replicated SNPs, we typed these six in another independent sample of 353 individuals with ileal Crohn disease and 207 controls ('replication cohort 2') on another independent genotyping platform (TaqMan). One of these failed to type, but the other five were successfully typed and provided additional evidence of replication ( Table 1 and Supplementary  Table 1 ). Considering the two replication studies together (using MantelHaenszel statistics), two of these SNPs were unequivocally confirmed as new Crohn disease risk factors: rs2241880 (P o 5 Â 10 À8 ) and rs224136 (P o 5 Â 10 À7 ). In combination with the genome-wide scan data, these two SNPs were considerably in excess of the most conservative genome-wide thresholds (rs2241880, P o 10 À13 ; rs224136, P o 10 À10 ). Three additional loci (rs16853571, rs4821544 and rs8050910) also showed evidence of replication (P o 0.01). Even after setting aside the two most significantly associated SNPs in the replication study (rs2241880 and rs224136), observing replication of 3/16 SNPs with P o 0.01 is highly unlikely to occur by chance (P ¼ 0.0005). As there is only a 1% probability of observing even two such results by chance, it is highly likely that these three SNPs represent true Crohn disease susceptibility variants; however, further confirmation is required to achieve the same level of certainty attained for IL23R, rs2241880 and rs224136.
Association mapping implicates new IBD genes
Given the significant evidence of replication for these five new loci, we examined the linkage disequilibrium (LD) structure surrounding the replicated SNPs using genotype data from the GWA screen, and we further examined the association mapping data from the GWA, replication studies and some additional higher-density typing in order to map these association signals to specific genomic regions and genes. In four instances, the association mapping implicated specific genes, whereas in the fifth, it implicated an intergenic region (Supplementary Fig. 1 online) . Specifically, the LD structure and association mapping around the most associated SNP (GWA, P ¼ 6.4 Â 10 -8 ; replication, P ¼ 4.1 Â 10 -8 ), rs2241880, implicated a region on chromosome 2q37.1 containing a single gene known as ATG16 autophagy-related 16-like 1 (ATG16L1). This SNP, which causes a nonsynonymous amino acid change in exon 8 (A197T), was recently shown 12 to be associated with Crohn disease in a genome-wide association scan of nonsynonymous SNPs. Logistic regression analyses conditional on A197T in the familybased samples indicated that this coding variant can fully explain the association signal to this locus; thus, we consider this to be the causal risk variant. In all data sets tested in this study, the threonine allele was the minor allele and had a protective effect; in the GWA data set, the estimated odds ratio was 0.692 (95% confidence interval (c.i.) 0.608-0.788). Notably, the threonine allele is ancestral and is the major allele in the YRI, JPT and HCB samples typed in the International HapMap Project ( Supplementary Fig. 2 online) . ATG16L1 is part of a family of genes involved in autophagy, a biological process involved in protein degradation, antigen processing, regulation of cell signaling and many other pathways essential to the initiation and regulation of the inflammatory response. Therefore, this association suggests that autophagy is likely to have an important role in disease pathogenesis.
The next SNP with very strong association to ileal Crohn disease was rs224136 (GWA, P ¼ 7.9 Â 10 -6 ; replication, P ¼ 2.9 Â 10 -7 ). In this case, however, the association mapping implicated a genomic region on chromosome 10q21.1 of approximately 70 kb that does not contain any known protein-coding genes. This associated intergenic region is flanked on the centromeric side by a zinc finger gene known as ZNF365, on the telomeric side by a predicted protein (c10orf 22) and by the known early growth response gene EGR2, which also encodes a zinc finger protein. Although there is little known about ZNF365 and c10orf 22, mutations in EGR2 are known to cause congenital hypomyelinating neuropathy (MIM#605253) or CharcotMarie-Tooth disease (MIM#607678). Potentially more relevant, however, is the observation that EGR2 seems to be a negative regulator of T cell activation in mice 13 ; thus, genetic variation within this intergenic region could potentially regulate EGR2 expression and influence its biological function.
The replicated SNP rs16853571 (GWA, P ¼ 7.7 Â 10 -7 ; replication, P ¼ 8.4 Â 10 -3 ) is located in the promoter region of the paired-like homeobox 2B (PHOX2B) gene on chromosome 4p13 (Supplementary Fig. 1 ), 2,143 bp upstream of the first known exon and 10 bp upstream of a putative alternate first exon. PHOX2B is a homeodomain transcription factor, predominantly expressed in differentiating neurons. Mutations in PHOX2B have been implicated in disorders of neural crest development, congenital central hypoventilation syndrome and Hirschsprung disease 14, 15 . Inactivation of Phox2b in mice disrupts noradrenergic differentiation throughout the nervous system; autonomic ganglia fail to develop properly, and these mice have marked defects in enteric neurons [15] [16] [17] .
The genomic region identified by rs4821544 (GWA, P ¼ 2.9 Â 10 -5 ; replication, P ¼ 9.0 Â 10 -3 ) also contains a single gene known as NCF4 (rs4821544 itself is in intron 1). NCF4 encodes the p40phox protein that has previously been shown to have an important role in NADPH oxidase activity and the generation of reactive oxygen species (ROS) upon phagocytosis 18, 19 -both important for mounting an effective antimicrobial response. Finally, rs8050910 (GWA, P ¼ 3.3 Â 10 -5 ; replication, P ¼ 8.5 Â 10 -3 ) is located within intron 4 of the predicted gene FAM92B located on chromosome 16q24.1. This gene prediction is supported by multiple mRNAs and spliced ESTs as well as by significant conservation across multiple species (data not shown). This gene encodes a protein with no known function or recognizable motifs.
Notably, when we used a stratified analysis approach, none of these three loci seemed to have any statistically significant epistatic interactions with CARD15, IBD5 or IL23R (data not shown). Although we saw some association with ulcerative colitis for rs224136, we saw little or no evidence for association with ulcerative colitis at the other newly identified SNPs (Supplementary Table 1 ).
RNA and protein expression analyses
As we were interested in determining more about ATG16L1's function and biological context, we examined the expression of ATG16L1 and other known autophagy components by quantitative real-time RT-PCR in a variety of epithelial and immune cell lines (Fig. 2a-c) . ATG5, ATG7 and ATG16L1 were broadly expressed, with SW480 cells having the lowest overall mRNA abundance relative to GAPDH controls. Apart from the markedly elevated levels of ATG7 seen in THP-1 cells, expression of each of the three components followed a similar pattern, as might be suggested by the stoichiometric relationship between these components in the homeostatic autophagy process. We also examined ATG16L1 expression in primary human immune cells to gain a better understanding of its role in the association with Crohn disease (Fig. 2d) . Among samples tested, we found that ATG16L1 was most highly expressed in the T cell compartment, with both CD4 + and CD8 + cells showing high levels (approximately 13-fold and tenfold higher than placental control RNA, respectively). CD19 + cells (B cells) also showed almost fivefold greater expression of ATG16L1 than both mononuclear cells and placental control RNA. Thus, it is possible that ATG16L1 and its variants have roles in both the epithelial and immunological aspects of Crohn disease.
PHOX2B is known to be expressed in the autonomic nervous system and enteric neurons 17 . We were not able to determine expression using real-time RT-PCR, most likely because expression was confined to specific cell types, and thus overall transcript levels were low in the tissues we studied. To overcome this limitation, we obtained a specific antibody and stained mouse and human gut samples (ileum and colon, respectively). These studies clearly showed that the PHOX2B protein was expressed in a specific subset of epithelial cells, possibly neuroendocrine cells ( Supplementary Fig. 3 online) .
NCF4 encodes p40phox, a component of the NADPH oxidase complex required for optimal ROS generation in immune cells. Expression is restricted to hematopoietic cells, including neutrophils, monocytes, eosinophils, mast cells and basophils ( Supplementary  Fig. 4 online and ref. 20) . The p40phox protein serves to enhance delivery of p47 and p67phox to the membrane, thus promoting highlevel ROS generation. However, its role in cells that do not generate high levels of ROS and lack expression of p47 and p67phox remains unknown.
RNA interference directed at ATG16L1 prevents autophagy Although the yeast homolog of ATG16L1 is required for autophagy 21 , it was not known whether the mammalian isoforms were similarly essential. We addressed this by using oligonucleotide-based short interfering RNAs (siRNAs) directed against ATG16L1 isoforms 1 and 2. Using cotransfection of a Flag-tagged ATG16L1 expression plasmid and siRNA oligonucleotides, we established specific knockdown of ATG16L1 in HEK293 cells (Fig. 3a) . To study the role of 
A R T I C L E S
ATG16L1 in autophagy during a well-characterized host-pathogen interaction, we performed ATG16L1 knockdown in HeLa cells followed by Salmonella typhimurium infection. We confirmed efficient knockdown of endogenous ATG16L1 in HeLa cells by real-time RT-PCR (Fig. 3b) . siRNA 2 was the most effective, so we used it in subsequent experiments cotransfected with a plasmid expressing GFP-LC3, a marker for the autophagic compartment 22 . A subpopulation of internalized S. typhimurium is targeted by autophagy in this system 23 . Infections with S. typhimurium showed a marked difference between control cells and cells treated with siRNA 2: control cells targeted a mean of 17.5% (± 1.3 s.e.m.) of intracellular bacteria to autophagic LC3 + vacuoles within 1 h, whereas siRNA 2 transfection reduced this to only 2% (± 0.5 s.e.m) (Fig. 3c) . The autophagic targeting rates in control-treated and ATG16L1-knockdown cells correspond well to those seen in Atg5 +/+ and Atg5 À/À mouse embryonic fibroblasts (20% and 3%, respectively) 23 , confirming that like ATG5, ATG16L1 is required for autophagy. Confocal imaging of infected cells demonstrated a near-complete lack of LC3 localization with intracellular bacteria in ATG16L1-knockdown cells, despite the presence of abundant cytoplasmic LC3-GFP and complete envelopment of targeted bacteria in control cells (Fig. 3d) . In addition, we used classical autophagic stimuli to show the inhibitory effect of ATG16L1 knockdown (Supplementary Fig. 5 online) ; both serum starvation and rapamycin treatment for 24 h induced LC3-GFP vesicles only in control siRNA-transfected cells and not in those with ATG16L1 knockdown. Inhibition of lysosome fusion by ammonium chloride also induced rapid accumulation of LC3 + vesicles in control cells, but we did not find these structures in cells treated with ATG16L1 siRNA ( Supplementary Fig. 5 ).
DISCUSSION
The potential of GWA studies to uncover modest genetic risk factors in complex disease has been widely debated. The simultaneous emergence of resources such as the data from the International HapMap Project and great leaps in genotyping technology (both of which were motivated by the potential of GWA studies) has now enabled the actual test of this hypothesis. In the case of Crohn disease, years of research effort by a substantial international community of researchers had identified only two uniformly replicated, genuinely associated genetic risk factors for this disease (CARD15 and IBD5).
Here, after only a moderately-sized GWA study and modest replication attempts, we present strong evidence for replicable associations between variation at IL23R, ATG16L1 and an intergenic region on 10q and ileal Crohn disease. Moreover, the list of replicated loci may grow even further in a short period of time, given the excess of additional low P values in this study (in particular, three additional top-ranking SNPs (in PHOX2B, NCF4 and FAM92B) that replicated at P o 0.01) combined with potential results from other ongoing large GWA studies for Crohn disease. In fact, reports describing genome-wide association studies of 735 German individuals with Crohn disease and 547 Belgian individuals with Crohn disease have recently been published 12, 24 . In the German study, after association analyses of 7,159 nonsynonymous SNPs, the A197T allele in ATG16L1 was found to be replicably associated with Crohn disease, confirming this gene's involvement in Crohn disease susceptibility 12 . However, in contrast to our findings, others 12 have reported an epistatic interaction with CARD15. It should be noted, however, that rather than an aberrant joint frequency estimates in affected individuals (as would be expected in the case of epistasis promoting a rare disease), the interaction signal in that study was due mostly to deviation from expectation in the control genotypes. Although this is possible for some genetic models, it requires a careful investigation. Furthermore, since different IBD genes show different degrees of phenotypic specificity, genes that promote the same specific sub-phenotype may be perceived as interacting if that specificity is not accounted for in the analyses. In the Belgian study 24 , which used the Illumina HumanHap300 Genotyping BeadChip, the authors identified an associated SNP (rs1373692) that implicated the prostaglandin receptor EP4 (PTGER4) gene in Crohn disease pathogenesis. In the current study, we also find evidence of association between ileal Crohn disease and SNP rs1373692 (P ¼ 5.37 Â 10 -4 ) as well as with SNP rs4613763 (P ¼ 1.21 Â 10 -4 ) less than 40 kb away, providing the first replication of this finding. Full release and integration of results from these and other ongoing studies should add further to this burgeoning list of confirmed associations. Undoubtedly, there are limitations to the GWA approach, so complementary strategies for gene discovery will continue to be necessary 25 . One limitation is related to typing large enough collections of samples to have sufficient statistical power to detect loci of very modest genetic effect 25 . One example from our current study is the lack of genome-wide significant association of the IBD5 haplotype, despite the fact that this is a confirmed Crohn disease risk haplotype 26 and that in a targeted replication study performed with replication cohort 1 presented here, we found significant evidence of replication 27 . It should be noted, however, that the strength of the association of the IBD5 haplotype in the current GWA study is consistent with modest risk conferred by this locus 28 . Although we recognize the limitations inherent to the GWA study design, these current and future association findings have the potential to greatly change our understanding of the biological processes that are crucial to disease pathogenesis, given the fact that genome-wide searches are not biased by our current understanding of pathogenic mechanisms. A prime example of this is the discovery that ATG16L1 is associated with IBD, given that this gene, or the biological pathway of autophagy to which it belongs, was not previously implicated in IBD pathogenesis before the current generation of genome-wide scans.
Autophagy is a constitutive process required for proper cellular homeostasis and organelle turnover. However, recent data have uncovered a role for autophagy in innate and adaptive immune responses to pathogens 29 . This places autophagy as a gatekeeper for innate immune ligands and antigen presentation from intracellular compartments. So far, the role of autophagy in innate immune recognition has been little studied, but several systems have been identified that show a potential role in host defense [30] [31] [32] . We have exploited a model system using the invasive bacterium S. typhimurium in cultured human epithelial cells 23 to show that, in addition to classical autophagic stimuli such as serum starvation and rapamycin, ATG16L1 is required for autophagic targeting of a subset of intracellular S. typhimurium exposed to the cytoplasm. Although we do not propose that this represents the physiological stimulus involved in Crohn disease, we do believe it provides initial evidence that ATG16L1 variants with altered autophagic efficiency or efficacy might alter either bacterial replication and immune control or delivery of antigens to adaptive immune pathways. For example, interactions between innate immunity, the inflammasome and autophagy have been proposed for Legionella pneumophila 33 . The proposed mechanism relies upon a NOD-LRR family member (Naip5) to detect invading L. pneumophila and subsequently activate autophagy or proinflammatory cell death via caspase 1. Associations between the response to microbial products and chronic intestinal inflammation have been noted for flagellin: both colitic mice and individuals with Crohn disease show elevated anti-flagellin serum IgG 34 . As it is now known that toll-like receptor 7 (TLR7)-mediated detection of viral replication is autophagy dependant 35 , it is tempting to speculate that differential autophagic effectiveness might enhance defects in nucleotide-binding oligomerization domain (NOD)-leucine-rich repeat (LRR) family and TLR signaling from intracellular pathogens.
Adaptive responses are also influenced by autophagic processing, as HLA class II molecule loading occurs in lysosomes, and autophagy delivers cytoplasmic components into this compartment. Antigen loading via this pathway has been observed in 'professional' antigenpresenting cells, as well as in epithelial cells 36 . In cells with low levels of endocytosis, such as epithelial cells, this is likely to be an important route for antigen presentation and immune surveillance 37 . It is possible that differential rates or substrate specificities induced by variation within the autophagic apparatus will result in differential antigen presentation, as has been observed for B cells in starvation stress 37 . In many models of Crohn disease and other inflammatory disorders, T cells are the primary effectors, and autophagy is a vital process for T cell maintenance and homeostasis, as demonstrated by the increased cell death seen in Atg5 À/À T cells and their inability to proliferate after stimulation 38 . T cells may also be stimulated directly by bacterial products in the gut microenvironment, as demonstrated by the discovery of the I2 superantigen 39 . Given the role of autophagy in controlling T cell death and proliferation, ATG16L1-mediated alterations in the proliferative and survival abilities of T cells provide a possible explanation for some of the T cell-driven pathology observed in Crohn disease. The relationships between T cell survival and regulation and the ATG16L1 variants discussed here will be an important area for further study.
Although our observation of potential association of NCF4 with ileal Crohn disease is not unequivocally confirmed, the known functions of this gene warrant further examination. In particular, previous studies of the p40phox protein encoded by NCF4 have shown that it is important in NADPH oxidase activity and the generation of ROS production upon phagocytosis 18, 19 , both of which are important for mounting an effective antimicrobial response. An alteration in NCF4 expression could have a potential effect on phagosome function, with less effective killing of phagocytosed microbes resulting in prolonged immune activation or incomplete pathogen clearance, or it might influence TLR activation and antigen presentation owing to inappropriate ROS generation 40, 41 . Thus, we propose that mutations in NCF4 might interfere with the stoichiometry of interaction with p67 and other p47phox-interacting partners, resulting in relatively moderate phagosome dysfunction phenotypes sufficient to trigger the onset of IBD.
Although additional functional studies are required to place all of these new risk loci into a biological context that will enable a deeper understanding of their roles in normal homeostasis and disease pathogenesis, there can be little question that the successful application of robust GWA studies offers opportunities for advances in the understanding and eventual treatment of Crohn disease.
METHODS
Subject ascertainment and diagnostic classification. The Screening Cohort used for this GWA study consisted of 988 individuals with ileal Crohn disease and 1,007 controls from the North American NIDDK IBDGC. Affected individuals and geographically matched controls were ascertained through the Cedars-Sinai Medical Center, Johns Hopkins University, University of Chicago, University of Montreal, University of Pittsburgh and the University of Toronto Genetics Research Centers (GRCs), with additional age and ethnicity-matched controls provided by the New York Health project. Informed consent was obtained from all participants, and protocols were approved by the local institutional review board in all participating institutions. The diagnosis of IBD requires (i) one or more of the following symptoms: diarrhea, rectal bleeding, abdominal pain, fever or complicated perianal disease; (ii) occurrence of symptoms on two or more occasions separated by at least 8 weeks or ongoing symptoms of at least 6 weeks' duration and (iii) objective evidence of inflammation from radiologic, endoscopic and histologic evaluation. Ileal Crohn disease involvement was defined as mucosal ulceration, cobblestoning, stricturing or bowel wall thickening from endoscopy reports, barium X-rays, operative reports and/or pathology resection specimen reports. This was an inclusive definition, where individuals with either 'ileal only' or 'ileocolonic' were part of the 'ileal Crohn disease' category. We have previously reported the association between IL23R and IBD from a genome-wide study of 567 individuals with Crohn disease and 571 controls 11 . These samples were included in the current study, as well as an additional 421 individuals with ileal Crohn disease and 436 control individuals ascertained in an identical manner.
Replication cohort 1 consisted of 883 nuclear families and was independent of the screening cohort. These study subjects, collected by the same IBDGC Genetics Research Centers as described above, have been described previously 11 and included 650 individuals with ileal Crohn disease and their parents. The replication cohort 1 was typed for 19/23 SNPs that had significant association (P o 5 Â 10 -5 ) in the GWA screen (CARD15 and IL23R had been typed previously, and two other SNPs failed at the assay design stage).
Replication cohort 2 consisted of 978 individuals with IBD (353 of which had ileal Crohn disease as defined above) and 207 control individuals ascertained as part of ongoing genetic studies at the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center. Recruitment of subjects was approved by the Cedars-Sinai Medical Center Institutional Review Board. Replication cohort 2 was typed for the six SNPs that had significant evidence of replication (P o 0.05) in replication cohort 1 (rs2241880, rs16853571, rs224136, rs4821544, rs8050910 and rs11617463).
Genotyping methods. For the genome-wide association study, approximately 750 ng of genomic DNA was used to genotype each sample on the Illumina HumanHap300 Genotyping BeadChip (Illumina) at the Feinstein Institute for Medical Research. Samples were processed according to the Illumina Infinium 2 assay manual. Briefly, each sample was whole genome amplified, fragmented, precipitated and resuspended in appropriate hybridization buffer. Denatured samples were hybridized on prepared HumanHap300 BeadChips for a minimum of 16 h at 48 1C. After hybridization, the BeadChips were processed for the single-base extension reaction and staining and imaging on an Illumina Bead Array Reader. Normalized bead intensity data obtained for each sample were loaded into the Illumina Beadstudio 2.0 software, which converted fluorescence intensities into SNP genotypes. We performed the replication study of the all of the putative loci (Table 1 ) and the additional genotyping of the ATG16L1 region using primer extension chemistry and mass spectrometric analysis (iPlex assay, Sequenom) using Sequenom Genetics Services. We used TaqMan MGB technology for genotyping of the six variants with nominal replication in replication study #1 using the design available from Applied Biosystems and following the manufacturer's recommendations (bulletin #4317594) in the Cedars-Sinai Inflammatory Bowel Disease Center cohort. The quality of the SNP data was checked by reproducibility, with 5% of samples duplicated.
Analysis of GWA data. Overall, 98.6% of genotypes were called in this experiment; however, before analysis, we performed quality filtering of both samples and SNPs to ensure robust association tests. Based on an evaluation of empirical distributions, data quality and likely introduction of false-positive associations, we required that samples pass a 93% genotyping call rate threshold and that SNPs pass a 95% call rate threshold in order to be included in the analysis ( Supplementary Fig. 6 online) . The data from the genome-wide association studies were used to detect possible relatedness in the case-control studies. The HWE test was performed on the genotype data from controls, and we investigated the relationship between HWE and genotype yield (call rate). The call rate distribution suggested a 93% and 95% genotype completion threshold for inclusion of samples and SNPs, respectively, in the genetic association analyses. At sample call rates of 90% and below, there was an elevation in observed heterozygosity, suggesting either a bias in missing data or the presence of false heterozygous calls. To avoid this, we selected a threshold
greater than 90 at a point consistent with the tail of successful samples. Below SNP success of 95%, there was an excess of markers out of HWE (P o 0.001 in controls) and a significant bias in missing data between cases and controls. We looked at segments of the data just above and below this cutoff and observed that SNPs with a 90%-95% call rate had much more substantial inflation than those in the 95%-97% call rate range (genomic control correction, 1.34 versus 1.16), indicative of significant excess of false positives owing to lower data quality or biases in missing data, so we opted not to lower this threshold further. As a final step, using identity-by-state (IBS) counts from this data set, we identified eight duplicate samples and ten additional pairs of samples that shared 10% or more of their genome by descent (first cousins through full siblings); we eliminated one member of each of these 18 pairs of samples. The data from the Jewish and non-Jewish case-control cohorts were analyzed jointly using a Cochran-Mantel-Haenszel w 2 test; we used the test as implemented in R (see URL below) with the option that gives an exact P value.
Analysis of replication study data. For the replication study, we selected the most significantly associated SNP from the top 23 independently associated regions (P ¼ 5 Â 10 À5 in the combined screening analyses). Of these, two failed in assay design, one failed to type and two were located within previously reported associated loci, leaving 18 SNPs in the replication analysis. In addition to these, 19 additional SNPs were selected to test the variability in the ATG16L1 region. This set of SNPs was evaluated for replication in a family-based ileal Crohn disease cohort composed of 650 mother-father-affected offspring trios. The genotype data from the family-based cohorts were used in determining mendelian inconsistencies and departures from HWE. After we removed failing SNPs (monomorphic, call rate below 75% and causing a high number of Mendel errors), families with excess mendelian inconsistencies and uninformative families (in which a parent or the sole affected offspring had a genotyping call rate below 90%), there remained 530 affected trios (from 431 independent nuclear families) with both parents and at least one affected offspring genotyped. After we removed additional SNPs causing excess Mendel errors, the final genotyping call rate for each of the 18 replication markers, as well as the 19 ATG16L1 tagging SNPs, ranged from 90%-100%, and mendelian inconsistencies were below four for all markers and fewer than four per family. Single-marker association tests were performed in the family data using PLINK (see URL below). We then tested the replicated SNPs in the set of 530 independent IBD trios (after quality control) from the NIDDK IBDGC and in the independent Cedars-Sinai cohort of 350 individuals with ileal Crohn disease and 207 controls; one-tailed P values are reported. The analysis of ATG16L1 SNPs conditional on A197T was performed by logistic regression in the family-based sample using the software WHAP (see URL below). mRNA analysis of ATG16L1. RNA templates were purified from cell lines using the RNeasy miniprep kit (Qiagen). In the case of human primary immune cell subsets, RNA was purchased from a commercial supplier (Human Blood Fractions MTC Panel, Clontech). In all cases, cDNA was made from RNA templates using a standard reverse transcriptase protocol (iScript, BioRad) using 500 ng of RNA per reaction. The resulting template cDNAs were diluted 1:10 in nuclease-free water, and 10 ml of this template used for each 40-ml quantitative RT-PCR reaction. Quantitative RT-PCR was performed using the real-time SYBR Green method on a BioRad iQ5 thermal cycler, using iQ SYBR Green Supermix (BioRad) and specific primers. Primer sequences used were selected using Massachusetts General Hospital (MGH) PrimerBank (see URL below); all primer sequences are shown in Supplementary Table 2 online. PCR products were visualized on a 2% agarose gel to confirm correct band sizes. Each reaction was performed in duplicate, with final calculations resulting from means of duplicate wells. Normalization for cDNA quantity was performed with GAPDH control primers for each template and final abundance figures adjusted to yield an arbitrary value of 1 for control templates (SW480 for cell lines or placental control RNA for primary cells) using the DDCt method.
Immunohistochemistry for localization of PHOX2B in mouse and human gut tissues. Paraffin-embedded tissues from both mouse ileum and human colon biopsies were dewaxed, rehydrated, blocked in serum and stained using rabbit antibody to PHOX2B (Sigma), incubated overnight at a dilution of 1:500. Tissues were subsequently incubated with biotinylated rabbit-specific secondary antibody and Vector ABC reagent and were then developed with DAB substrate (Vector Laboratories) as previously described 42 . Sections were mounted and observed under phase contrast to visualize tissue architecture.
Cell lines and bacterial strain. HeLa cells were obtained from ATCC and cultured in DMEM supplemented with 10% iron-supplemented calf serum (Hyclone) and 20 mg ml -1 gentamicin sulfate (Sigma). Salmonella enterica sbsp. enterica serovar typhimurium (S. typhimurium) strain SL1344 was transformed with a DsRed2 expression plasmid (Clontech) (DsRed2 is under the control of the lac promoter, which is constitutive in the absence of lacI) to facilitate bacterial visualization. The plasmid was maintained with 100 mg ml -1 ampicillin selection during culture in LB broth.
siRNA directed against ATG16L1. We obtained modified siRNA duplexes (Stealth siRNA) directed against ATG16L1 (siRNA 1 and siRNA 2) as well as a nontargeting scrambled sequence (siRNA control) from a commercial source (Invitrogen). Cells were cotransfected in the absence of antibiotics with siRNAs and plasmids using Lipofectamine (Invitrogen) according to the manufacturer's instructions. We optimized siRNA conditions using a Flag-tagged overexpression ATG16L1 construct in HEK293 cells, allowing us to easily assess knockdown by protein blotting. HEK293 cells grown in 12-well plates were transfected with 500 ng Flag-ATG16L1 expression plasmid and 20 pmol siRNA duplex. For knockdown of endogenous ATG16L1, HeLa cells were plated onto 18-mm glass coverslips in 12-well plates at a density of 1 Â 10 5 per well and were allowed to grow for 24 h before transfection. Each well received 500 ng of GFP-LC3 plasmid and 20 pmol siRNA duplex. After 4 h, the medium was changed again and the cells were allowed to grow for a further 48 h. Knockdown was confirmed for each experiment using real-time quantitative RT-PCR with primers specific to ATG16L1, with results normalized to GAPDH controls and RNA isolated from specimen wells.
Induction of autophagy and bacterial infection. Autophagy was induced in HeLa cells using serum starvation or rapamycin. Cells were transfected as described above, and after 48 h, the medium was changed to either 1% serum or 10% serum plus 200 nM rapamycin for a further 24 h. Ammonium chloride treatment was performed with a final concentration of 50 mM for 2 h in 1% serum medium. S. typhimurium infections were performed as previously described, with slight modifications 43 . Briefly, S. typhimurium SL1344 carrying a DsRed2 expression plasmid was grown overnight in LB broth containing 100 mg ml -1 ampicillin at 37 1C with aeration and then was subcultured at a dilution of 1:33 for a further 3 h in LB. This culture was further diluted in DMEM 10% iron-supplemented calf serum without antibiotics, to yield a multiplicity of infection of 100. Infections were allowed to proceed for 20 min. Cells were then washed once in complete medium containing 100 mg ml -1 gentamicin sulfate and incubated in fresh high-gentamicin medium for 1 h.
Microscopy. Infected, autophagy-induced and control HeLa cells were fixed in 4% formalin in PBS for 15 min, washed in PBS and mounted in aqueous mountant (Polysciences). Slides were then either viewed under wide-field fluorescence illumination (Zeiss Axioplan) for counting, or laser scanning confocal microscopy (BioRad Radiance 2000) was used to obtain highresolution z stacks, which were subsequently projected onto single images using LSM Image software (Carl Zeiss). The total number of bacteria per cell and the number of LC3-GFP-positive bacteria were assessed in randomly chosen fields with at least 100 cells counted for each condition. The numbers of LC3-GFP positive bacteria were then calculated as a percentage of total bacteria. Significance was assessed using the two-tailed, unequal variance Student's t-test.
URLs. R: http://www.r-project.org/; PLINK: http://pngu.mgh.harvard.edu/ purcell/plink/; WHAP: http://pngu.mgh.harvard.edu/~purcell/whap; MGH PrimerBank: http://pga.mgh.harvard.edu/primerbank/.
Note: Supplementary information is available on the Nature Genetics website.
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